Ledger.Open graph →
SEC Form D · filed September 24, 2012

INFINITY PHARMACEUTICALS, INC

Offering
$78.5M
Sold
$78.5M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (16)

Thomas J. Lynch · New York, NYDirectorNorman C. Selby · Ann Arbor, MIDirectorAdelene Q. Perkins · Cambridge, MAExec · DirectorJulian Adams · Cambridge, MAExecVito J. Palombella · Cambridge, MAExecPedro Santabarbara · Cambridge, MAExecSteve H. Holtzman · Cambridge, MADirectorMartin Babler · Cambridge, MADirectorAnthony B. Evnin · Atlanta, GADirectorGwen A. Fyfe · Cambridge, MADirectorEric S. Lander · Cambridge, MADirectorPatrick P. Lee · Cambridge, MADirectorThomas J. Lynch · Waltham, MADirectorNorman C. Selby · Cambridge, MADirectorIan F. Smith · Cambridge, MADirectorMichael C. Venuti · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗